HOME
ABOUT US
OUR PLATFORM
INVESTORS
NEWS
CONTACT
IMPRESSUM
Mehr
Ymmunobio and EVIIVE announce collaboration to develop advanced liquid biopsy for detecting NPTXR in cancer patients
Ymmunobio is proud to announce our ASCO publication on YB-800
Ymmunobio has been selected for the Venture Leaders Biotech 2024!
Dr. Katrin Rupalla Interviewed by Global Business Reports
Drug Discovery & Development
Fierce Biotech: Appointment of Michel Janicot
Thanks for subscribing!